Edwards Lifesciences Corporation Financial Ratios — EW Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	17.39	17.89	19.78	31.64	15.12	14.74	18.46	28.41	30.48	17.98	25.24	20.36	15.69	35.58	7.48
Return on Assets (%)	12.63	13.87	15.78	26.03	13.06	13.3	11.47	13.14	17.73	12	19.1	18.12	15.89	37.24	8.03
Return on Capital (%)	16.42	16.38	16.81	26.06	13.14	12.78	14.59	22.36	26.17	15.9	22.85	18.85	14.71	33.6	7.25
Return on Invested Capital (%)	17.32	19.51	18.49	13.65	17.11	18.31	15.08	25.69	25.5	23.07	23.46	20.32	18.75	14.33	12.1
Gross Margin (%)	70.82	74.15	74.74	73.07	75.25	73.09	74.52	74.77	74.37	75.36	76.13	83.79	80.47	79.46	78.01
EBITDA Margin (%)	21.33	24.93	26.17	23.73	28.42	28.89	31.96	30.89	30.54	32.46	32.9	37.61	32.56	30.06	29.55
Operating Margin (%)	17.88	22.1	23.1	20.78	25.78	26.48	29.57	28.81	28.49	30.02	30.33	34.48	29.66	27.21	26.97
Incremental Operating Margin (%)	6.82	54.21	36.05	3.64	93.85	30.21	48.98	19.76	26.55	203.39	31.93	6.21	-9.69	-1.42	24.85
Pretax Margin (%)	16.9	20.44	24.99	49.25	24.96	24.9	30.13	20.45	26.83	20.9	32.53	34.04	27.39	28.46	20.98
Profit Margin (%)	14.1	15.35	19.02	34.92	19.85	19.22	16.99	19.4	24.08	18.77	28.73	34.09	27.99	76.75	17.69
Net Income to Common Margin (%)	14.1	15.35	19.02	34.92	19.85	19.22	16.99	19.4	24.08	18.77	28.73	34.09	27.99	76.75	17.69
Effective Tax Rate (%)	16.54	24.91	23.88	29.1	20.49	22.82	43.61	5.15	10.25	10.18	11.69	12.87	11.1	9.82	17.04
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	17.39	17.89	19.78	31.64	15.12	14.74	18.46	28.41	30.48	17.98	25.24	20.36	15.69	35.58	7.48

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	150	189	593	598	597	822	1,036	594	679	695	690	691	685	700	705
ST Debt	- -	- -	- -	- -	- -	- -	598	- -	26	27	26	26	23	23	24
LT Debt	150	189	593	598	597	822	438	594	653	668	665	666	662	677	681
Total Debt/EBITDA	0.42	0.4	1.11	1.09	0.84	0.96	0.94	0.52	0.51	0.49	0.4	0.41	0.42	0.43	0.39
Net Debt/EBITDA	-0.06	-0.26	0.32	-0.1	-0.17	-0.13	0.2	-0.1	-0.44	-0.41	-0.16	-0.1	-0.33	-1.5	-1.31
Total Debt/EBIT	0.5	0.45	1.26	1.24	0.93	1.05	1.02	0.55	0.55	0.53	0.44	0.45	0.46	0.47	0.43
Net Debt/EBIT	-0.07	-0.29	0.37	-0.12	-0.19	-0.14	0.21	-0.11	-0.47	-0.45	-0.17	-0.11	-0.36	-1.65	-1.43
EBITDA to Interest Expense	115.52	107.64	54.63	32.05	41.2	44.59	47.32	38.46	64.15	90.11	93.57	87.43	92.68	82.59	87.88
EBITDA-CapEx/Interest Expense	113.03	106.05	54.52	31.42	40.98	42.44	47	38.36	63	90.09	93.35	86.38	91.92	81.08	87.88
EBIT to Interest Expense	96.81	95.43	48.21	28.06	37.38	40.88	43.79	35.88	59.84	83.33	86.24	80.16	84.44	74.75	80.21
Interest Expense	3	4	10	17	17	19	23	30	21	16	18	19	18	20	20
Common Equity/Total Assets	74.76	80.04	79.59	84.33	88.16	91.99	38.37	54.66	61.03	71.87	78.92	99.32	102.99	105.87	108.78
Long-Term Debt/Equity (%)	11.24	12.8	38.4	27.29	23.85	31.4	14.83	18.91	15.75	14.6	11.39	11.47	9.86	6.72	6.59
Long-Term Debt/Capital (%)	9.22	9.62	21.57	16.76	14.3	16.54	13.66	16.95	14.08	11.32	8.98	7.46	6.37	4.64	4.36
Long-Term Debt/Total Assets (%)	7.59	8.52	21.89	16.98	14.72	18.23	7.74	11.15	10.07	9.23	7.82	8.03	7.07	5.18	4.97
Total Debt/Equity (%)	11.24	12.8	38.4	27.29	23.85	31.4	35.06	18.91	16.36	15.19	11.83	11.91	10.2	6.96	6.82
Total Debt/Capital (%)	9.22	9.62	21.57	16.76	14.3	16.54	32.28	16.95	14.63	11.79	9.33	7.74	6.59	4.8	4.52
Total Debt/Total Assets (%)	7.59	8.52	21.89	16.98	14.72	18.23	18.29	11.15	10.46	9.6	8.12	8.34	7.32	5.36	5.15
Net Debt to Equity	-1.55	-8.22	11.18	-2.54	-4.85	-4.12	7.38	-3.83	-14.09	-12.86	-4.58	-2.97	-7.97	-24.32	-22.63
Net Debt/Capital (%)	-1.42	-7.34	7.41	-1.91	-3.52	-2.67	9.12	-4.31	-16.9	-12.48	-4.09	-2.12	-5.78	-21.21	-18.47
EBITDA	358	474	535	551	709	856	1,098	1,150	1,328	1,424	1,722	1,679	1,631	1,635	1,793
EBITDA-CapEx	350	467	534	540	705	815	1,090	1,147	1,304	1,424	1,718	1,658	1,618	1,605	1,793
Operating Income (Loss)	300	420	472	483	643	785	1,016	1,073	1,239	1,317	1,587	1,539	1,486	1,480	1,636

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	1.34	1.5	2.71	3.38	2.57	2.39	0.94	1.09	1.68	1.57	1.42	1.19	1.37	2.64	2.33
Current Ratio	3.49	3.72	4.99	5.24	4.3	4.21	1.8	2.61	3.31	3.46	3.08	3.03	3.38	4.18	3.72
Quick Ratio	2.3	2.5	3.66	4.14	3.35	3.17	1.28	1.7	2.34	2.24	2.07	1.87	2.06	3.12	2.83
CFO/Avg Current Liab	0.92	1.06	1.36	2.65	1.22	1.4	1.03	0.81	1.33	1.17	1.8	1.19	0.81	0.4	0.96
Common Equity/Total Assets	74.76	80.04	79.59	84.33	88.16	91.99	38.37	54.66	61.03	71.87	78.92	99.32	102.99	105.87	108.78
Long-Term Debt/Equity (%)	11.24	12.8	38.4	27.29	23.85	31.4	14.83	18.91	15.75	14.6	11.39	11.47	9.86	6.72	6.59
Long-Term Debt/Capital (%)	9.22	9.62	21.57	16.76	14.3	16.54	13.66	16.95	14.08	11.32	8.98	7.46	6.37	4.64	4.36
Long-Term Debt/Total Assets (%)	7.59	8.52	21.89	16.98	14.72	18.23	7.74	11.15	10.07	9.23	7.82	8.03	7.07	5.18	4.97
Total Debt/Equity (%)	11.24	12.8	38.4	27.29	23.85	31.4	35.06	18.91	16.36	15.19	11.83	11.91	10.2	6.96	6.82
Total Debt/Capital (%)	9.22	9.62	21.57	16.76	14.3	16.54	32.28	16.95	14.63	11.79	9.33	7.74	6.59	4.8	4.52
Total Debt/Total Assets (%)	7.59	8.52	21.89	16.98	14.72	18.23	18.29	11.15	10.46	9.6	8.12	8.34	7.32	5.36	5.15
CFO/Total Liabilities	47.96	48.79	40.56	76.77	35.39	37.25	36.92	42.44	50.56	39.59	64.95	49.01	33.88	18.12	47.48
CFO/CapEx	40.03	51.73	429.73	94.66	144.66	17.06	135.23	308.9	49.29	3,514.33	433.02	60.31	67.35	18.08	- -
Altman's Z-Score	11.13	12.18	7.32	9.33	10.04	9.89	7.94	12.1	15.71	15.9	21.24	14.46	13.81	12.29	12.36

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	5.98	6.28	6.56	7.87	8.27	8.71	8.54	8.31	8.69	8.29	9.54	7.29	7.08	7.88	9.57
Days Sales Outstanding	61	58.11	55.64	46.39	44.16	41.93	42.72	43.9	41.99	44.03	38.25	50.09	51.53	46.32	38.16
Inventory Turnover	2.11	1.81	1.75	2.07	1.94	2.17	1.84	1.62	1.79	1.5	1.63	0.9	1.1	1.12	1.21
Days Inventory Outstanding	173.22	201.57	208.39	176.69	188.27	168.56	198.39	225.73	204.36	243.74	223.43	404.04	331.84	325.02	302.69
Accounts Payable Turnover	8.26	6.4	8.85	11.51	10.82	10.61	9.67	7.91	7.3	6.59	5.85	4.29	5.18	6.77	6.47
Accounts Payable Turnover Days	44.2	57.07	41.26	31.71	33.75	34.4	37.73	46.13	49.97	55.38	62.37	85.01	70.45	53.88	56.45
Cash Conversion Cycle	190.03	202.61	222.77	191.38	198.68	176.09	203.38	223.5	196.39	232.39	199.31	369.12	312.91	317.46	284.4
Inventory to Cash Days	-112.22	-143.45	-152.76	-130.3	-144.11	-126.63	-155.66	-181.82	-162.37	-199.71	-185.18	-353.95	-280.31	-278.7	-264.53
Inventories	261	281	309	297	340	397	555	607	641	802	727	876	904	1,087	1,126
Raw Materials	52	50	58	67	64	61	101	112	118	137	133	156	196	241	197
Work In Process	67	59	82	59	64	102	121	145	122	140	164	177	196	236	253
Finished Goods	143	173	169	170	212	234	332	351	401	526	430	542	511	609	677
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	8,102	10,361	7,345	13,566	17,020	19,958	23,771	32,043	48,594	56,800	80,749	46,184	46,261	44,248	49,854
- Cash & Cash Equivalents	171	311	420	654	718	930	818	714	1,179	1,183	863	769	1,132	3,045	2,938
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	69	64	- -
+ Total Debt	150	189	593	598	597	822	1,036	594	679	695	690	691	685	700	705
Enterprise Value	7,802	10,028	7,002	12,725	16,392	19,509	23,469	31,680	47,756	56,092	79,972	45,660	45,383	41,036	46,333
Total Capital	1,631	1,967	2,750	3,569	4,173	4,971	3,210	3,504	4,638	5,896	7,400	8,928	10,397	14,586	15,605
Total Debt/Capital (%)	9.22	9.62	21.57	16.76	14.3	16.54	32.28	16.95	14.63	11.79	9.33	7.74	6.59	4.8	4.52
Total Debt / EV	0.02	0.02	0.08	0.05	0.04	0.04	0.04	0.02	0.01	0.01	0.01	0.02	0.02	0.02	0.02
EV/Sales	4.65	5.28	3.42	5.48	6.57	6.58	6.83	8.51	10.98	12.79	15.28	10.23	9.06	7.54	7.64
EV/EBITDA	21.79	21.17	13.08	23.09	23.13	22.79	21.38	27.55	35.96	39.4	46.45	27.2	27.82	25.09	25.84
EV/EBIT	26	23.88	14.82	26.37	25.5	24.86	23.1	29.53	38.55	42.6	50.4	29.67	30.54	27.73	28.32
EV/Cash Flow to Firm	25.1	27.44	14.58	12.3	29.1	27.13	23.15	33.17	39.75	52.5	45.74	36.97	49.79	73.26	28.74
EV/Free Cash Flow to Firm	24.5	26.93	14.55	12.17	28.9	25.65	22.98	33.07	38.97	52.48	45.64	36.38	49.08	69.53	28.74
Diluted Market Cap	8,442	10,667	7,483	13,821	17,399	20,408	24,334	32,717	49,504	57,648	81,772	46,572	46,467	44,366	49,939
Diluted Enterprise Value	8,421	10,546	7,656	13,765	17,278	20,300	24,552	32,597	49,004	57,160	81,599	46,494	46,089	42,085	47,707
EV per Share	11.35	14.55	10.45	19.91	25.36	30.53	37.09	50.48	76.42	90.09	128.3	73.76	74.8	68.66	79.23
TTM Sales	1,679	1,900	2,046	2,323	2,494	2,964	3,435	3,723	4,348	4,386	5,232	4,464	5,010	5,440	6,068
TTM EBITDA	358	474	535	551	709	856	1,098	1,150	1,328	1,424	1,722	1,679	1,631	1,635	1,793
TTM Operating Income	300	420	472	483	643	785	1,016	1,073	1,239	1,317	1,587	1,539	1,486	1,480	1,636
TTM Cash Flow to Firm	311	365	480	1,034	563	719	1,014	955	1,201	1,068	1,748	1,235	911	560	1,612
TTM Free Cash Flow to Firm	318	372	481	1,045	567	761	1,021	958	1,225	1,069	1,752	1,255	925	590	1,612

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	26.72	28.9	15.79	13.38	31.44	27.37	24.14	35.19	41.02	54.66	47.1	37.61	51.11	77.52	31.31
EV/EBIT	26	23.88	14.82	26.37	25.5	24.86	23.1	29.53	38.55	42.6	50.4	29.67	30.54	27.73	28.32
Enterprise Value	7,802	10,028	7,002	12,725	16,392	19,509	23,469	31,680	47,756	56,092	79,972	45,660	45,383	41,036	46,333
Low Price	10.26	11.31	10.1	10.51	20.46	24.07	28.85	36.89	46.95	51.51	78.44	67.13	60.57	58.93	65.94
EV/Sales	4.65	5.28	3.42	5.48	6.57	6.58	6.83	8.51	10.98	12.79	15.28	10.23	9.06	7.54	7.64
EV/EBITDA	21.79	21.17	13.08	23.09	23.13	22.79	21.38	27.55	35.96	39.4	46.45	27.2	27.82	25.09	25.84
Price/Earnings	34.23	35.54	18.88	16.73	34.39	35.04	40.73	44.37	46.42	68.98	53.72	30.35	32.99	10.6	46.44
Price/Earnings Average	38.31	34.6	21.24	12.05	31.09	37.06	38.68	41.22	39.76	57.53	42.56	39.52	34.1	11.27	41.77
Price/Earnings High	44.46	43.67	27.27	17.63	36.33	45.54	43.89	50.69	49.27	69.62	54.63	53.32	41.04	13.76	47.88
Price/Earnings Low	29.82	26.75	17.4	8.28	26.73	27	31.28	32.06	28.03	38.95	32.53	27.3	26.2	8.44	35.92
Price/Book Value	5.47	5.83	3.41	4.57	4.76	4.81	10.93	11.01	12.27	10.92	12.03	5.61	4.8	3.2	3.35
Price/Book Value Average	6.12	5.67	3.83	3.29	4.3	5.09	10.38	10.23	10.51	9.11	9.53	7.3	4.96	3.4	3.01
Price/Book Value High	7.11	7.16	4.92	4.81	5.03	6.25	11.78	12.58	13.03	11.02	12.24	9.85	5.97	4.16	3.45
Price/Book Value Low	4.77	4.39	3.14	2.26	3.7	3.71	8.4	7.96	7.41	6.17	7.29	5.05	3.81	2.55	2.59
Price/Tangible Book Value	8.8	10.08	6.53	7.57	10.2	11.16	17.46	19.02	18.38	18.5	18.59	10.6	8.94	6.22	6.7
Price/Tangible Book Value Average	9.84	9.82	7.34	5.45	9.22	11.8	16.58	17.67	15.74	15.43	14.73	13.8	9.24	6.62	6.03
Price/Tangible Book Value High	11.42	12.39	9.43	7.98	10.77	14.5	18.81	21.73	19.51	18.68	18.9	18.62	11.12	8.08	6.91
Price/Tangible Book Value Low	7.66	7.59	6.02	3.75	7.92	8.6	13.4	13.74	11.1	10.45	11.25	9.54	7.1	4.95	5.18
Price/Sales	4.83	5.45	3.59	5.84	6.83	6.73	6.92	8.61	11.18	12.95	15.43	10.35	9.23	8.13	8.22
Price/Sales Average	5.4	5.31	4.04	4.21	6.17	7.12	6.57	8	9.57	10.8	12.23	13.47	9.55	8.65	7.39
Price/Sales High	6.27	6.7	5.19	6.16	7.21	8.75	7.46	9.83	11.86	13.07	15.69	18.18	11.49	10.56	8.47
Price/Sales Low	4.2	4.1	3.31	2.89	5.3	5.19	5.31	6.22	6.75	7.31	9.34	9.31	7.33	6.48	6.36
Price/Cash Flow	26.29	28.61	15.54	13.27	30.96	28.33	23.75	34.58	41.08	53.87	46.62	37.91	51.64	81.59	31.25
Price/Cash Flow Average	29.42	27.86	17.48	9.56	27.99	29.97	22.56	32.12	35.18	44.93	36.94	49.37	53.39	86.74	28.11
Price/Cash Flow High	34.14	35.16	22.44	13.99	32.71	36.82	25.6	39.51	43.61	54.38	47.4	66.62	64.25	105.94	32.22
Price/Cash Flow Low	22.9	21.53	14.32	6.57	24.06	21.83	18.24	24.99	24.8	30.42	28.23	34.11	41.02	64.95	24.17
Price/Free Cash Flow Average	29.91	28.14	17.77	9.64	28.41	28.94	22.92	32.69	35.13	45.59	37.32	48.97	52.85	82.41	28.16
Price/Free Cash Flow High	34.71	35.51	22.81	14.1	33.21	35.56	26.01	40.21	43.54	55.17	47.89	66.08	63.59	100.65	32.28
Price/Free Cash Flow Low	23.28	21.75	14.56	6.62	24.43	21.09	18.54	25.43	24.77	30.86	28.52	33.84	40.6	61.71	24.21
EV/Sales Average	5.39	5.25	4.12	4.18	6.12	7.09	6.63	7.96	9.46	10.69	12.19	13.46	9.47	8.23	7.02
EV/Sales High	6.26	6.64	5.27	6.13	7.16	8.71	7.52	9.8	11.75	12.96	15.66	18.16	11.41	10.14	8.1
EV/Sales Low	4.19	4.04	3.39	2.87	5.26	5.15	5.38	6.19	6.63	7.2	9.31	9.29	7.26	6.06	5.99
EV/EBITDA Average	25.26	21.04	15.76	17.63	21.54	24.53	20.76	25.78	30.96	32.93	37.06	35.78	29.09	27.37	23.77
EV/EBITDA High	29.33	26.62	20.14	25.85	25.2	30.17	23.53	31.73	38.47	39.92	47.59	48.3	35.06	33.74	27.42
EV/EBITDA Low	19.65	16.21	12.97	12.08	18.49	17.84	16.83	20.03	21.72	22.18	28.3	24.71	22.3	20.14	20.26
EV/EBIT Average	30.15	23.73	17.85	20.13	23.74	26.76	22.44	27.64	33.2	35.61	40.21	39.03	31.93	30.24	26.04
EV/EBIT High	34.99	30.03	22.82	29.52	27.78	32.9	25.43	34.02	41.24	43.17	51.64	52.68	38.47	37.27	30.05
EV/EBIT Low	23.45	18.28	14.7	13.8	20.38	19.46	18.18	21.47	23.28	23.99	30.7	26.95	24.47	22.26	22.2
Last Price	11.78	15.03	10.96	21.23	26.33	31.23	37.57	51.06	77.76	91.23	129.55	74.61	76.25	74.03	85.25
High Price	15.3	18.46	15.83	22.38	27.81	40.58	40.48	58.33	82.55	92.08	131.73	131.1	94.87	96.12	87.89
Enterprise Value Average	9,047	9,966	8,436	9,717	15,263	21,000	22,792	29,647	41,120	46,885	63,804	60,065	47,451	44,758	42,613
Enterprise Value High	10,502	12,608	10,782	14,246	17,859	25,825	25,832	36,490	51,083	56,841	81,935	81,073	57,180	55,170	49,165
Enterprise Value Low	7,037	7,676	6,944	6,658	13,105	15,271	18,471	23,034	28,841	31,580	48,719	41,476	36,370	32,942	36,329

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	685	686	656	647	646	635	629	623	627	624	624	608	601	589	581
Diluted Weighted Avg Shares	716	710	683	651	661	653	648	641	637	632	631	624	609	599	586
Basic Weighted Avg Shares	688	689	670	639	646	639	633	628	625	623	623	619	607	598	585
Revenue per Share	2.44	2.76	3.05	3.64	3.86	4.64	5.43	5.93	6.96	7.05	8.39	7.21	8.26	9.1	10.38
EBITDA per Share	0.52	0.69	0.8	0.86	1.1	1.34	1.74	1.83	2.13	2.29	2.76	2.71	2.69	2.74	3.07
Operating Income per Share	0.44	0.61	0.71	0.76	0.99	1.23	1.61	1.71	1.98	2.11	2.55	2.49	2.45	2.48	2.8
Basic EPS, GAAP	0.34	0.42	0.58	1.27	0.77	0.89	0.92	1.15	1.68	1.32	2.41	2.46	2.31	6.98	1.84
Basic EPS from Cont Ops	0.34	0.42	0.58	1.27	0.77	0.89	0.92	1.15	1.68	1.32	2.41	2.14	2.01	2.34	1.81
Diluted EPS, GAAP	0.33	0.41	0.57	1.25	0.75	0.87	0.9	1.13	1.64	1.3	2.38	2.44	2.3	6.97	1.83
Diluted EPS from Cont Ops	0.33	0.41	0.57	1.25	0.75	0.87	0.9	1.13	1.64	1.3	2.38	2.12	2	2.33	1.8
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	0.45	0.53	0.71	1.6	0.85	1.1	1.58	1.48	1.89	1.69	2.78	1.97	1.48	0.91	2.73
Free Cash Flow per Basic Share	0.44	0.52	0.7	1.58	0.84	1.04	1.57	1.47	1.85	1.69	2.77	1.94	1.45	0.86	2.73
Cash & Equivalents per Share	0.66	0.76	1.4	2.25	1.89	1.99	2.11	1.52	2.43	2.25	2.35	1.96	2.69	6.65	7.23
Book Value per Share	2.15	2.58	3.22	4.65	5.53	6.49	3.44	4.64	6.34	8.35	10.77	13.31	15.89	23.12	25.48
Tangible Book Value per Share	1.34	1.49	1.68	2.8	2.58	2.8	2.15	2.68	4.23	4.93	6.97	7.04	8.53	11.89	12.72

Edwards Lifesciences Corporation

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)